MariMed Reports Fourth Quarter and Full Year 2024 Earnings

Stock Information for C21 Investments Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About C21 Investments Inc

MariMed's Premium Nature's Heritage Brand Enters Functional Mushroom Market Launching Plant-Based MycroDose
MariMed Reports First Quarter 2025 Earnings
MariMed Announces First Quarter 2025 Earnings Date
MariMed Promotes Ryan Crandall to Chief Commercial Officer
MariMed's Betty's Eddies Expands Top-Selling Brand With Introduction of THC & CBG-Infused Caramel Chews
MariMed Launches Nature's Heritage(TM) Flower in Illinois
MariMed Completes Acquisition of First State Compassion, Strengthening Market Position in Delaware
MariMed Announces Fourth Quarter and Full Year 2024 Earnings Date

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.